Ventricular assist device thrombosis: A wide spectrum of clinical presentation

Funding

E.Y.B. and J.E.R. received training and research grant support from Thoratec Corporation and HeartWare. L.R.G. is a consultant for Thoratec, St. Jude and Respircardia. K.B.M. is on the advisory committees for Novo Nordisk and Astra-Zeneca and received research grant support from Juventis Therapeutics, Celladon, Thoratec, Innolign Biomedical and the U.S. National Institutes of Health (HL105993, HL110338, HL113777). The remaining authors have no conflicts of interest to disclose. The authors thank Dr Michael Acker, Dr Hansie Mathelier, Dr Sourin Banerji, Dr Jeremy A. Mazurek, Christyna M. Justice and Rhondalyn McLean for their contribution to the study. K.B.M. and J.E.R. contributed equally to this work.